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IMPORTANCE—Use of assisted reproductive technology (ART) has been associated with 
increased risks for birth defects. Variations in birth defect risks according to type of ART 
procedure have been noted, but findings are inconsistent.
OBJECTIVES—To examine the prevalence of birth defects among liveborn infants conceived 
with and without ART and to evaluate risks associated with certain ART procedures among ART-
conceived infants.
DESIGN, SETTING, AND PARTICIPANTS—Used linked ART surveillance, birth certificates, 
and birth defects registry data for 3 states (Florida, Massachusetts, and Michigan). Methods for 
ascertaining birth defect cases varied by state. Resident live births during 2000 to 2010 were 
included, and the analysis was conducted between Feburary 2015 and August 2015.
EXPOSURES—Use of ART among all live births and use of certain ART procedures among 
ART births.
MAIN OUTCOME AND MEASURES—Prevalence of selected chromosomal and 
nonchromosomal birth defects that are usually diagnosed at or immediately after birth.
RESULTS—Of the 4 618 076 liveborn infants between 2000 and 2010, 64 861 (1.4%) were 
conceived using ART. Overall, the prevalence of 1 or more of the selected nonchromosomal 
defects was 58.59 per 10 000 for ART infants (n = 389) vs 47.50 per 10 000 for non-ART infants 
(n = 22 036). The association remained significant after adjusting for maternal characteristics and 
year of birth (adjusted risk ratio [aRR], 1.28; 95%CI, 1.15–1.42). Similar differences were 
observed for singleton ART births vs their non-ART counterparts (63.69 per 10 000 [n = 218] vs 
47.17 per 10 000 [n = 21 251]; aRR, 1.38; 95%CI, 1.21–1.59). Among multiple births, the 
prevalence of rectal and large intestinal atresia/stenosis was higher for ART births compared with 
non-ART births (aRR, 2.39; 95%CI, 1.38–4.12). Among ART births conceived after fresh embryo 
transfer, infants born to mothers with ovulation disorders had a higher prevalence of 
nonchromosomal birth defects (aRR, 1.53; 95%CI, 1.13–2.06) than those born to mothers without 
the diagnosis, and use of assisted hatching was associated with birth defects among singleton 
births (aRR, 1.55; 95%CI, 1.10–2.19). Multiplicity-adjusted P values for these associations were 
greater than .05.
CONCLUSIONS AND RELEVANCE—Infants conceived after ART had a higher prevalence of 
certain birth defects. Assisted hatching and diagnosis of ovulation disorder were marginally 
associated with increased risks for nonchromosomal birth defects; however, these associations 
may be caused by other underlying factors.
In 2012, approximately 1.5%of liveborn infants in the United States were conceived using 
assisted reproductive technology (ART), defined as fertility treatments in which eggs or 
embryos are handled outside the body.
1
 Since the birth of the first ART-conceived infant in 
the United States in 1981, ART use has increased rapidly; more than 157000 cycles were 
performed in 2012.
2
 Although ART is generally considered safe, findings from registry-
based cohort studies
3–5 andmeta-analyses,
6–8 primarily conducted in non-US populations, 
suggest that children conceived with ART have increased risks for birth defects compared 
with their spontaneously conceived counterparts, particularly among singleton infants.
Boulet et al. Page 2













Information on the degree to which certain ART procedures influence the risk of birth 
defects is limited and often in conclusive. Results from a 2012 cohort study
3
 indicated that 
use of intracytoplasmic sperm injection (ICSI), a procedure in which a single sperm is 
injected directly into an egg, was associated with increased odds of birth defects relative to 
spontaneously conceived pregnancies, whereas no effect was noted for conventional in vitro 
fertilization (IVF) without ICSI. However, pooled risk estimates for the association between 
birth defects and conventional IVF vs those for the association between birth defects and 
ICSI have not been found to be markedly different.
6,7
Similarly, while several studies comparing fresh and frozen-thawed embryo transfers 
identified similar risks for birth defects regardless of embryo state,
5,9–12 1 study found an 
increased prevalence of birth defects for fresh but not frozen embryo cycles when compared 
with spontaneously conceived births.
3
 In addition, results from another study indicated that 
the odds of blastogenesis defects were 3 times higher for ART births after fresh embryo 
transfer vs non-ART controls, while no effect was found for frozen-thawed embryo 
transfers.
13
 There is insufficient evidence to evaluate the risk of birth defects following the 
use of other ART procedures such as assisted hatching
14,15 and donor oocytes
16
 or for 
embryo stage at transfer.
17,18
Because both ART and birth defects are infrequent events, sufficiently powered studies are 
needed to evaluate associations, particularly with regard to specific ART procedures. Thus, 
the aim of our study was to use population-based data from 3 US states to assess the 
prevalence of birth defects among liveborn infants conceived using ART compared with 
their non-ART counterparts and to examine the risk of birth defects associated with different 
types of ART procedures among ART-conceived infants.
Methods
We used data from the States Monitoring ART (SMART) Collaborative, a consortium of 
participating states and the Centers for Disease Control and Prevention Division of 
Reproductive Health that promotes state-based surveillance and research on the maternal and 
child health outcomes of ART.
19
 We used linked ART surveillance, birth certificates, and 
birth defects registry data for Florida, Massachusetts, and Michigan from 2000 to 2010. 
These states linked their birth defects registry information with birth certificate data and 
provided deidentified linked data sets to the Centers for Disease Control and Prevention. 
Then, data from the Centers for Disease Control and Prevention’s National ART 
Surveillance System were linked with the state vital records information using a 
probabilistic method. Maternal and infant date of birth, plurality, maternal residence zip 
code, and gravidity (live birth order plus pregnancy losses) were primary linkage variables.
20 
Ancillary information such as maternal race/ethnicity, infant sex, and infant birth weight 
were used to resolve duplicate links. The overall linkage rate was 90.5%.
Key Points
Question
Is assisted reproductive technology associated with an increased risk of birth defects?
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In this cohort study of more than 4 million liveborn infants in 3 states, the prevalence of 
nonchromosomal birth defects among singleton infants was higher for those conceived 
using assisted reproductive technology compared with non–assisted reproductive 
technology singletons. This difference was significant after controlling for maternal 
characteristics.
Meaning
Infants conceived after assisted reproductive technology had a higher prevalence of 
certain birth defects; however, this association could be owing to underlying subfertility.
We included all resident live births in Florida, Massachusetts, and Michigan between 2000 
and 2010; ART births were those that were successfully linked with the National ART 
Surveillance System. We excluded births with missing information on plurality and ART 
births using methods other than transcervical IVF such as gamete intrafallopian transfer and 
zygote intrafallopian transfer (<1%for all states). The unit of analysis was a liveborn infant. 
The study was approved by the institutional review boards at the Centers for Disease Control 
and Prevention, Florida Department of Health, Massachusetts Department of Health, and 
Michigan Department of Health and Human Services. Informed consent was waived because 
the research involved no more than minimal risk, the rights and welfare of the subjects were 
not adversely affected, and the research could not practicably be carried out without such a 
waiver.
The methods for ascertaining birth defect cases varied by state. The Florida Birth Defects 
Registry uses passive case-finding methods and ascertains birth defects diagnosed in 
liveborn infants before 1 year of age. Records are identified from hospital discharge 
abstracts, the state regional perinatal center database, and the state Children’s Medical 
Services records and are linked to birth certificates. The Massachusetts Birth Defects 
Monitoring Program uses active case finding whereby birth hospitals and pediatric care 
facilities submit discharge records with a birth defect diagnosis. Inclusion critera are being a 
liveborn infant or a fetal death of more than 20 weeks’ gestation or weighing more than 350 
g, having a structural defect that meets the diagnostic criteria and was diagnosed before 1 
year of age, and being born to mothers who were residents of the state at the time of 
delivery. The Michigan Birth Defects Registry uses passive case ascertainment based on 
reporting from hospitals, cytogenetic laboratories, and pediatric genetics clinics. Reporting 
is required for liveborn infants diagnosed with a reportable condition before the second 
birthday and for fetal deaths after 20 weeks’ gestation or more or after they reach 400 g or 
higher. Michigan data are augmented by information from Children’s Special Health Care 
Services enrollments; confirmed cases are identified as a result of newborn metabolic, 
hearing, or genetic screening and linked birth and death record information.
Because of differences in case ascertainment across states, we evaluated a limited number of 
birth defects. We selected defects that were used in previously published national 
estimates
21,22 because they are usually diagnosed at or immediately after birth and are likely 
to be consistently collected and reported across different surveillance systems. The 
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nonchromosomal birth defects assessed in this study were spina bifida with or without 
anencephaly, encephalocele, anophthalmia and microphthalmia, common truncus, 
transposition of great arteries, tetralogy of Fallot, atrioventricular septal defects, hypoplastic 
left heart syndrome, cleft palate without cleft lip, cleft lip with and without cleft palate, 
esophageal atresia/tracheoesophageal fistula, rectal and large intestinal atresia/stenosis, 
reduction defects of the upper limbs, reduction defects of the lower limbs, gastroschisis, 
omphalocele, and diaphragmatic hernia. The chromosomal defects were trisomy 13, trisomy 
21 (Down syndrome), and trisomy 18.
We examined the distribution of sociodemographic factors for all ART and non-ART 
liveborn infants. The variables were derived from the birth certificate and included maternal 
state of residence, age, race/ethnicity, education, parity (derived from live birth order), 
tobacco use during pregnancy, diabetes (chronic or gestational), hypertension (chronic or 
pregnancy-induced), infant plurality, sex of the infant, birth weight, and gestational age. We 
also compared the prevalence of birth defects for all ART and non-ART births and stratified 
by singleton and multiple births. For all comparisons, chromosomal defects were stratified 
by maternal age younger than 35 years and 35 years and older because of known age 
effects.
23
 The prevalence of specific birth defects was reported if the defect was diagnosed 
in 20 or more infants.
Next, we restricted the study population to ART-conceived infants and evaluated the 
prevalence of 1 or more nonchromosomal birth defects for certain ART procedures including 
cycle type (fresh nondonor, fresh donor, frozen-thawed nondonor, or frozen-thawed donor 
embryos), number of embryos transferred, use of assisted hatching (the purposeful 
disruption of an embryo’s zona pellucida by laser, mechanical, or chemical means), and 
infertility diagnosis (tubal factor, ovulation disorder, diminished ovarian reserve, 
endometriosis, male factor, or unexplained infertility). Because information on use of ICSI 
and day of embryo transfer was only available for fresh embryo cycles, we further restricted 
the study population to infants resulting from fresh embryo transfer and examined the 
prevalence of birth defects for all aforementioned procedures and ICSI with male factor 
infertility, ICSI without male factor infertility, and day of embryo transfer (days 2–3 vs days 
5–6). We conducted the analyses for all live births and singleton live births; small numbers 
precluded evaluation of multiple live births.
We used 2-tailed Satterthwaite-adjusted χ2 tests to assess differences in the distribution of 
sociodemographic characteristics for ART vs non-ART liveborn infants. We used 
multivariable predicted marginal proportions from logistic regression models to compute 
adjusted risk ratios for the association between use of ART and birth defects. The models 
were adjusted for maternal age, race/ethnicity, education, parity, smoking during pregnancy, 
diabetes, hypertension, state of residence, and year of birth. We also used predicted marginal 
proportions to calculate adjusted risk ratios for the association between use of specified ART 
procedures and nonchromosomal birth defects. Models for births resulting from fresh and 
frozen-thawed embryo transfers included cycle type, number of embryos transferred, use of 
assisted hatching, and infertility diagnosis. Models for births resulting from fresh embryo 
transfers included type of ART (conventional IVF vs ICSI with and without male factor 
infertility), cycle type, number of embryos transferred, day of transfer, use of assisted 
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hatching, and infertility diagnosis. Because information on maternal body mass index was 
not available for Massachusetts during the study period and was only available from autumn 
2007 onward for Michigan and March 2004 onward for Florida, we were unable to evaluate 
this factor as a potential confounder. We applied the Holm-Bonferroni method to the primary 
and subgroup analyses to account for multiple comparisons and report multiplicity-adjusted 
P values. P values less than .05 were considered significant.
All analyses accounted for clustering of infants within a live birth delivery and clustering of 
sibling births. We used SAS version 9.3 (SAS Institute) and SUDAAN version 11.0 (RTI 
International) for analysis. Cohort sizes of less than 20 infants were suppressed and 
complementary suppression was applied.
Results
Between 2000 and 2010, there were 4 618 076 liveborn infants in Florida, Massachusetts, 
and Michigan; of those infants, 64 861 (1.4%)were conceived using ART. Compared with 
non-ART infants, those conceived using ART had higher frequencies of multiple births, a 
birth weight of less than 2500 g and less than 1500 g, and gestational age of less than 37 
weeks and less than 32 weeks (Table 1). There was no difference in the distribution of infant 
sex. Approximately 45.8%(n = 29 736) of ART-conceived infants were born to mothers who 
were Massachusetts residents, compared with 18.7%(n = 853 165) of non-ART infants. 
Mothers of ART infants were more likely to be 30 years or older, non-Hispanic white, 
college graduates, and nulliparous than mothers of non-ART infants. Tobacco use during 
pregnancy was less common in mothers of ART vs non-ART infants, while diabetes and 
hypertension were more common in mothers of ART infants.
Among all liveborn infants, the prevalence of 1 or more selected nonchromosomal defects 
was 59.97 per 10 000(n = 389) for ART infants compared with 48.40 per 10 000 (n = 22 
036) for non-ART infants (Table 2). After adjusting for maternal characteristics and year of 
birth, ART use was associated with an increased risk for nonchromosomal birth defects 
(adjusted risk ratio [aRR], 1.28; 95%CI, 1.15–1.42). Tracheoesophageal fistula/esophageal 
atresia (aRR, 1.93; 95% CI, 1.40–2.67), rectal and large intestinal atresia/stenosis (aRR, 
2.03; 95%CI, 1.51–2.74), and reduction deformity of the lower limbs (aRR, 2.18; 95%CI, 
1.39–3.43) were positively associated with ART use.
Among singleton live born infants, the prevalence of 1 or more selected nonchromosomal 
defects was 64.88 per 10 000 (n = 218) for ART infants compared with 48.07 per 10 000 (n 
= 21 251) for non-ART infants, and this association with ART remained significant in the 
adjusted model (aRR, 1.39; 95%CI, 1.21–1.59) (Table 3). Likewise, the prevalence of 
tracheoesophageal fistula/esophageal atresia (aRR, 1.90; 95% CI, 1.23–2.94) and rectal and 
large intestinal atresia/stenosis (aRR, 1.88; 95% CI, 1.26–282) was higher for ART births vs 
non-ART births. For women younger than 35 years, the prevalence of Down syndrome was 
higher for ART vs non-ART births (aRR, 1.63; 95% CI, 1.05–2.54), but the association was 
not significant after accounting for multiple comparisons (P = .18). For women 35 years and 
older, the prevalence of chromosomal defects was lower for ART births than non-ART births 
(aRR, 0.66; 95%CI, 0.49–0.88). With the exception of increased risk for rectal and large 
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intestinal atresia/stenosis (aRR, 2.39; 95% CI, 1.38–4.12), no significant associations with 
ART were observed for multiple births.
When the study population was restricted to ART births conceived by fresh or frozen 
embryo transfer, no significant associations between ART procedures and risk of 1 or more 
nonchromosomal birth defects were detected (Table 4). After further restriction to ART 
births conceived by fresh embryo transfer, diagnosis of ovulation disorder was marginally 
associated with nonchromosomal defects among all live births (aRR, 1.53; 95% CI, 1.13–
2.06; P = .05) (Table 5). The prevalence of nonchromosomal defects was also increased for 
all live births (aRR, 1.32; 95% CI, 1.02–1.71) and singleton live births where assisted 
hatching was used (aRR, 1.55; 95% CI, 1.10–2.19); however, the multiplicity-adjusted P 
values were >.05.
Discussion
Using data from a national ART surveillance system linked with vital records and 
information from 3 state-based birth defects registries, we found that ART use was 
associated with an increased risk for certain birth defects. These findings confirm previous 
reports based on smaller populations
3–5 and provide additional information on variations in 
risk according to the type of ART procedure used. While we did not find considerable 
differences in risk by procedure type, the prevalence of nonchromosomal defects was higher 
for ART births where assisted hatching was used compared with ART births without the 
technique; however, the association was not statistically significant after accounting for 
multiple comparisons. Two studies that assessed the risk of birth defects following assisted 
hatching did not detect an effect
14,15; however, such an association is plausible because the 
procedure could damage the embryo and is often used for patients with a poor prognosis 
who may have other risks for adverse birth outcomes.
24
 In addition, we observed a 
marginally increased prevalence of nonchromosomal defects among births to women with an 
ovulation disorder, a finding that may be associated with high rates of obesity, a known risk 
factor for birth defects,
25
 among women with polycystic ovary syndrome.
26
 While we 
adjusted for diabetes in our models, it is possible that undiagnosed diabetes among obese 
women with polycystic ovary syndrome may partially explain this association.
Overall, the prevalence of the selected birth defects in our study population is consistent 
with national estimates.
22
 However, because we used a limited group of conditions, our 
prevalence estimates of 1% are lower than national estimates for all types of birth defects 
(approximately 3%).
27
 In accordance with other studies,
3–5,7,28–32 we found that the risk of 
birth defects following ART varied by type of defect; the largest relative risks were observed 
for gastrointestinal and limb reduction defects. We also found an association between ART 
use and transposition of great vessels, which has been previously reported.
33
 The 
consistency of our results with those of other studies and meta-analyses that assessed a 
broader group of birth defects suggests that the excess risk observed in our study is robust. 
The apparent negative association between ART and Down syndrome in women 35 years or 
older is probably because of the use of preimplantation genetic screening among older 
women, primarily for aneuploidy.
34
 Notably, in women younger than 35 years, we found 
increased prevalence of Down syndrome among ART singleton infants compared with non-
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ART singletons. The reason for this association is unknown but may be caused by different 
attitudes toward pregnancy termination in younger women undergoing ART compared with 
women of the same age with spontaneous conceptions. Overall, older women tend to be 
more likely than younger women to terminate a pregnancy following a Down syndrome 
diagnosis
35
; thus, there may be additional factors among younger women using ART that 
influence their opinions on termination. It is also possible that younger women with an ART-
conceived pregnancy were less willing to undergo chorionic villus sampling or 
amniocentesis because of heightened concerns about risks to the fetus, leading to differences 
in the rates of prenatal diagnosis and consequent terminations. Another potential explanation 
is that young women undergoing ART have more serious underlying health issues than older 
women and thus have poorer-quality embryos.
We did not find a significantly higher prevalence of selected nonchromosomal birth defects 
in ART births where ICSI was used vs those where conventional IVF was used after 
adjusting for patient and treatment characteristics. While this finding corroborates the results 
of meta-analyses published in 2012 and 2013,
6,7 our study did not include genitourinary 
defects, specifically, hypospadias and cryptorchidism, which are most often implicated in 
studies of ICSI and birth defects and which may be related to severe male factor 
infertility.
36,37 Similarly, we did not find an association between birth defects and use of 
donor oocytes or embryo stage at transfer; however, association with the transfer of 2 or 
more fresh embryos approached significance, particularly for singleton live births, 
suggesting that singletons originating from pregnancies where multiple embryos implanted 
may have increased risks for birth defects. Notably, the presence of a vanishing twin has 
been identified as a risk factor for small for gestational age in singleton births after IVF.
38
The primary strength of our study is the use of a large population- and registry-based cohort 
with accurate information on ART procedures. To our knowledge, this is the largest US 
study of birth defects and ART to date. Furthermore, we limited our analysis to birth defects 
that are apparent at birth and thus likely to be reliably ascertained across different states. 
However, our findings have several limitations. First, we did not have information on the 
occurrence of birth defects among fetal deaths or pregnancy terminations. As such, our 
prevalence estimates almost certainly understate the true prevalence of the birth defects 
included in our study. This may also result in risk ratios that are biased toward or away from 
the null,
39
 depending on the extent to which mothers of ART infants are more or less likely 
than mothers of non-ART infants to have a miscarriage or terminate a pregnancy affected by 
birth defects. It is also possible that differences in case ascertainment across states 
influenced the combined prevalence estimates. Assisted reproductive technology–conceived 
infants may be monitored more closely, thus resulting in increased detection of birth defects 
in those infants compared with the general population. Because of variations among states in 
the collection of information on maternal body mass index, we were unable to control for 
this potential confounder. Finally, some of the birth certificate variables used in the 
adjustment are under- reported and may be differentially reported among ART and non-ART 
groups.
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We found that ART use conferred an increased risk for nonchromosomal birth defects, 
particularly those affecting the gastrointestinal and musculoskeletal systems; however, we 
were unable to evaluate the potential effect of underlying subfertility on this association. 
Among ART births, no single procedure was found to substantially increase risk, although 
use of assisted hatching and diagnosis of ovulation disorders were associated with marginal 
increases in the prevalence of birth defects. In total, these findings suggest that factors 
related to subfertility may explain the association between use of ART and birth defects, 
although additional studies on specific ART procedures are needed. As use of ART 
continues to increase, careful evaluation of the long-term outcomes of children conceived 
using these technologies becomes increasingly important. These findings provide additional 
information on risks of ART that can be used when counselling patients.
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Table 1




ART (n = 64 861) Non-ART (n = 4 553 215)
Plurality
 Singleton 33 601 (51.8) 4 421 154 (97.1)
 Twins 28 031 (43.2) 127 013 (2.8)
 Triplets/higher 3229 (5.0) 5048 (0.1)
Infant sex
 Male 33 213 (51.2) 2 331 340 (51.2)
 Female 31 648 (48.8) 2 221 767 (48.8)
Birth weight, g
 <2500 20 843 (32.2) 357 027 (7.8)
 <1500 4172 (6.4) 66 580 (1.5)
Gestational age, wk
 <37 23 456 (36.3) 444 005 (9.8)
 <32 4742 (7.3) 74 063 (1.6)
State of residence
 Florida 21 636 (33.4) 2 333 367 (51.2)
 Massachusetts 29 736 (45.8) 853 165 (18.7)
 Michigan 13 489 (20.8) 1 366 683 (30.0)
Maternal age, y
 <30 7480 (11.5) 2 742 518 (60.2)
 30–34 22 587 (34.8) 1 120 673 (24.6)
 35–37 15 228 (23.5) 411 713 (9.0)
 38–40 10 821 (16.7) 202 982 (4.5)
 ≥41 8745 (13.5) 75 161 (1.7)
Race/ethnicity
 Non-Hispanic white 52 636 (81.4) 2 651 395 (58.4)
 Non-Hispanic black 2629 (4.1) 823 410 (18.1)
 Hispanic 648 (1.0) 58 761 (1.3)
 Asian/Pacific Islander 5598 (8.7) 838 398 (18.5)
 Other/mixed 3159 (4.9) 165 831 (3.7)
Maternal education, y
 <12 883 (1.4) 794 055 (17.6)
 12 7788 (12.1) 1 378 011 (30.5)
 Some college 13 767 (21.3) 1 121 534 (24.8)
 College graduate 42 051 (65.2) 1 217 657 (27.0)
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Characteristica
No. (%)b
ART (n = 64 861) Non-ART (n = 4 553 215)
Parity
 Nulliparous 42 697 (66.1) 1 906 727 (42.0)
 Multiparous 21 884 (33.9) 2 628 451 (58.0)
Tobacco use during pregnancyc 806 (1.2) 463 004 (10.2)
Diabetesd 4501 (7.0) 184 442 (4.1)
Hypertensione 6386 (9.8) 232 898 (5.1)
Abbreviation: ART, assisted reproductive technology.
a
Missing data less than 1% for all variables.
b
P < .01 for all comparisons between ART births and non-ART births except for infant sex. P values account for clustering of infants within a live 
birth delivery and clustering of sibling births and were adjusted using the Holm-Bonferroni method.
c
Includes women who smoked during the pregnancy but quit for 2004 to 2010 Florida data and 2010 Michigan data.
d
Includes chronic and gestational diabetes.
e
Includes chronic and pregnancy-induced hypertension.
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